HOME >> BIOLOGY >> NEWS
Weill Cornell team identifies potential new cancer drug target

NEW YORK (June 20, 2007) -- Research led by scientists at Weill Cornell Medical College has uncovered two new potential points of vulnerability on a key cancer-promoting protein, called XIAP. Drugs that target either of these activities could help push cancer cells back into a more regular programmed cell death and thereby reduce or eliminate tumors.

These findings were published in the June 8 issue of Molecular Cell by Dr. Hao Wu, a professor in the Department of Biochemistry of Weill Cornell, and her team.

Experts know that cancers spread in two separate ways -- by the uncontrolled proliferation of cells, and by their refusal to undergo normal, healthy, programmed cell death, or "apoptosis."

In many cancers, dysfunction in a biochemical cascade called the NF-kappa B pathway causes tumor cells to sidestep apoptosis and become dangerously immortal.

"So, drug development aimed at short-circuiting NF-kappa B has become very hot in the past few years," Dr. Wu says.

Her team focused on a particular protein involved in the NF-kappa B pathway called the "X-linked inhibitor of apoptosis" (XIAP). Scientists had already discovered that XIAP thwarts the apoptotic impulse by putting the brakes on key enzymes called caspases. XIAP is also known to be highly active in cancer cells, but it is found in relatively low levels in healthy cells. How XIAP inhibits caspases is known, but how XIAP induces NF-kappa B activation is entirely unclear.

"We wondered if we could find out how XIAP induces the NF-kappa B pathway," explains lead researcher Dr. Miao Lu, a postdoctoral fellow of biochemistry at Weill Cornell.

In their experiments, the researchers used a variety of cutting-edge techniques, including X-ray crystallography, to track changes in the structure and activity of XIAP and the molecules it interacts with in cells.

"We discovered that XIAP interacts with the NF-kappa B cycle in two distinct wa
'"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
21-Jun-2007


Page: 1 2

Related biology news :

1. Weill Cornell pharmacologist receives prestigious NIH MERIT Award
2. Stem cell research at Weill Cornell, The Rockefeller University, and Sloan-Kettering
3. Weill Cornell team develops fast-acting anthrax vaccine
4. Cornell scientists link E. coli bacteria to Crohns disease
5. Methodist, University of Houston, Cornell combine biomedical imaging expertise
6. Cornell lab confirms deadly fish virus spreading to new species
7. NSF awards $3.3 million grant to Cornell to bolster the percentage of women faculty members
8. Cornell researchers find serious fish virus in Northeast for first time
9. Cornell finds natural selection in humans
10. Northeast Sun Grant Institute at Cornell spurs green revolution
11. Cornell graduate student named 2005 AIBS Emerging Public Policy Leader

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/14/2019)... ... December 11, 2019 , ... Fiberstar, ... food and beverage industry won the 2019 Food Ingredient Europe’s plant-based innovation award. ... rapidly growing plant-based foods category. Fiberstar who was one of three finalists achieved ...
(Date:12/4/2019)... (PRWEB) , ... December 04, 2019 , ... ... companies today, has launched Subnovii Advanced Plasma Technology for U.S. dermatologists, ... portfolio, Subnovii is the only plasma to employ LF technology – low frequency ...
(Date:11/27/2019)... ... 2019 , ... The MyOnyx rehab solution by ... that measure and display muscle activity in real time. This information helps the ... Both patient and therapist can see when exercises are performed correctly and efficiently. ...
Breaking Biology News(10 mins):
(Date:12/18/2019)... ... December 17, 2019 , ... Innovative Health, Inc. ... Electrophysiology (EP) devices since the company’s inception in 2016. This marks a record ... Johnson & Johnson company) have received 2 and 4 EP device clearances, respectively, ...
(Date:12/4/2019)... ... , ... A new survey by MedReps ( http://www.medreps.com ), a career site ... medical sales companies to work for in 2020. , The 9th Annual ... the MedReps community to identify which medical sales companies are currently the most sought-after ...
(Date:12/4/2019)... ... December 04, 2019 , ... The technology at the heart of Nanopareil ... potential impact on the pharmaceutical industry could be massive. , “The pharmaceutical industry really ... at South Dakota School of Mines & Technology and one of the ...
(Date:11/20/2019)... ... November 20, 2019 , ... Defense and ... microturbine electrical power generation units from 2019-2028. The value of this production is ... of 3,821 units worth $569 million. , Reference to 2017 is important, ...
Breaking Biology Technology:
Cached News: